State Of Wisconsin Investment Board Immuno Gen, Inc. Transaction History

State Of Wisconsin Investment Board

$37.8 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	BUY	$12.46 - $29.95 $156,497 - $376,172	12,560 Added 5.71%	232,462 $6.89 Million
Q3 2023 Nov 14, 2023	BUY	$14.09 - $19.87 $13,033 - $18,379	925 Added 0.42%	219,902 $3.49 Million
Q2 2023 Aug 14, 2023	BUY	$3.75 - $20.05 $134,006 - $716,486	35,735 Added 19.5%	218,977 $4.13 Million
Q1 2023 May 15, 2023	SELL	$3.67 - $4.92 $33,885 - $45,426	-9,233 Reduced 4.8%	183,242 $703,000
Q4 2022 Feb 14, 2023	SELL	$4.55 - $6.31 $55,701 - $77,247	-12,242 Reduced 5.98%	192,475 $954,000
Q3 2022 Nov 14, 2022	SELL	$4.48 - $6.47 $48,661 - $70,277	-10,862 Reduced 5.04%	204,717 $979,000
Q2 2022 Aug 15, 2022	SELL	$3.15 - $5.76 $92,991 - $170,040	-29,521 Reduced 12.04%	215,579 $970,000
Q1 2022 May 13, 2022	SELL	$4.26 - $7.48 $173,808 - $305,184	-40,800 Reduced 14.27%	245,100 $1.17 Million
Q4 2021 Feb 11, 2022	SELL	$4.75 - $7.5 $104,500 - $165,000	-22,000 Reduced 7.15%	285,900 $2.12 Million
Q3 2021 Nov 12, 2021	BUY	$5.02 - $6.59 $74,296 - $97,532	14,800 Added 5.05%	307,900 $1.75 Million
Q2 2021 Aug 12, 2021	BUY	$5.79 - $8.6 $64,269 - $95,460	11,100 Added 3.94%	293,100 $1.93 Million
Q1 2021 May 17, 2021	SELL	$6.5 - $10.53 $77,350 - $125,306	-11,900 Reduced 4.05%	282,000 $2.28 Million
Q4 2020 Feb 03, 2021	SELL	$3.7 - $7.66 $265,660 - $549,988	-71,800 Reduced 19.63%	293,900 $1.9 Million
Q3 2020 Nov 16, 2020	BUY	$3.45 - $4.89 $425,730 - $603,426	123,400 Added 50.93%	365,700 $1.32 Million
Q2 2020 Aug 12, 2020	BUY	$3.32 - $5.34 $61,420 - $98,790	18,500 Added 8.27%	242,300 $1.12 Million
Q1 2020 May 06, 2020	BUY	$2.12 - $6.8 $26,500 - $85,000	12,500 Added 5.92%	223,800 $763,000
Q2 2019 Aug 14, 2019	BUY	$1.8 - $3.3 $8,280 - $15,180	4,600 Added 2.23%	211,300 $459,000
Q1 2019 May 13, 2019	BUY	$2.41 - $5.91 $140,985 - $345,735	58,500 Added 39.47%	206,700 $560,000
Q4 2018 Feb 11, 2019	BUY	$3.94 - $9.7 $69,738 - $171,690	17,700 Added 13.56%	148,200 $711,000
Q2 2018 Aug 03, 2018	BUY	$9.52 - $12.15 $273,224 - $348,705	28,700 Added 28.19%	130,500 $1.27 Million
Q1 2018 May 07, 2018	BUY	$6.7 - $12.95 $293,460 - $567,210	43,800 Added 75.52%	101,800 $1.07 Million
Q3 2017 Nov 01, 2017	BUY	$5.4 - $8.47 $313,200 - $491,260	58,000	58,000 $444,000

Others Institutions Holding IMGN

# of Institutions

Shares Held

1.41M

Call Options Held

Put Options Held

View Full List

About ImmunoGen, Inc.

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

More about IMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wisconsin Investment Board with notifications on news.

Account